Source: International Congress 2016 – Pulmonary drug delivery



Rating:

Share or cite this content

Citations should be made in the following way:
Ross Hatley (Chichester, United Kingdom), Ross Hatley, Lucy Hardaker. Mesh nebulizer capabilities in aerosolizing a wide range of novel pharmaceutical formulations. Eur Respir J 2016; 48: Suppl. 60, 967

Member's Comments

No comment yet.

Related content which might interest you: Development of in-vitro models for aerosolized surfactant therapy to support customization of a novel nebulizer system based on eflow technology Source: Annual Congress 2009 - Respiratory disorders of the newborn Year: 2009 Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Characterisation of exhaled aerosol from vibrating mesh and jet nebulisers Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods Year: 2016 Development of a novel nano-sized carrier system for aeroseol drug delivery (EGE University translational pulmonology research group) Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 The mesh nebuliser: a recent technical innovation for aerosol delivery Source: ISSN=ISSN 1810-6838, ISBN=, page=252 Year: 2006 Novel jet nebulizer/holding chamber for drug delivery to the deep lung Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Measures of nebulizer performance – Comparing like with like Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 A novel approach of using pharmaceutical pictogram for improving asthma inhaler techniques Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 Assessment of two different methods of bronchodilators delivery during noninvasive ventilation. Experimental in vivo approach Source: Eur Respir J 2004; 24: Suppl. 48, 315s Year: 2004 Watching the lung work: An in vitro 3-D microfluidic device to challenge pulmonary drug delivery strategies with high end microscopy Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 The performance of a new vibrating mesh prototype nebulizer for inhaled biodrugs Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Comparative in vitro performance of the new drug aclidinium in a novel multidose dry powder inhaler Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Novel paradigm for inhaled therapies: simulation of drug pharmacokinetic behaviour and effect of disease Source: Eur Respir J 2003; 22: Suppl. 45, 474s Year: 2003 Systemic exposure and lung bioavailability across two different dose strengths of CHF5993 a novel Triple pMDI Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Delivery of a suspension corticosteroid formulation by small volume nebulizers: a comparative bench study Source: Eur Respir J 2001; 18: Suppl. 33, 134s Year: 2001 Workshop 1: Lung Clearance Index – demonstration of devices utilised by the core facility; best practices and different approaches to communication with pharmaceutical companies Source: International Congress 2016 – PD5 Establishing core facilities for measuring clinical trial outcomes  Year: 2016 Eliminating in-vitro drug-drug interactions in dual and triple fixed-dose combination therapies using a novel cosuspension metered dose inhaler platform Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Drug loaded liposomes of mesalamine incorporated into disease responsive microgels (Micro) for treating allergic asthma: An approach using smart drug delivery system Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Efficacy and safety of a new pleural device for the ambulatory management of pneumothorax Source: International Congress 2015 – Interventional pulmonology for pleural diseases Year: 2015 First in class, respiratory drug gas & drug vapor delivered in a revolutionary and new portable device Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015